Silence Therapeutics plc
SLN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20,958 | -$27,354 | -$22,084 | $22,891 |
| Dep. & Amort. | $156 | $148 | $138 | $119 |
| Deferred Tax | $1 | $10 | $0 | $0 |
| Stock-Based Comp. | $2,535 | $2,085 | $2,740 | $3,423 |
| Change in WC | $5,212 | -$4,502 | $6,747 | -$26,324 |
| Other Non-Cash | $2,163 | $7,829 | $150 | -$24,974 |
| Operating Cash Flow | -$10,891 | -$21,784 | -$12,309 | -$24,864 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$48 | -$4 | -$56 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$2,389 | -$70,060 | -$21,262 |
| Inv. Sales/Matur. | $0 | $875 | $0 | $91,431 |
| Other Inv. Act. | $51,292 | $0 | $25,683 | -$1,985 |
| Investing Cash Flow | $51,289 | -$1,562 | -$44,381 | $68,129 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $49 |
| Stock Issued | $0 | $1 | $14 | -$17,684 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $37,513 |
| Financing Cash Flow | $0 | $1 | $14 | $19,878 |
| Forex Effect | -$106 | $198 | $232 | $6,975 |
| Net Chg. in Cash | $40,292 | -$23,147 | -$56,444 | $59,377 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $41,739 | $64,886 | $121,330 | $82,906 |
| End Cash | $82,031 | $41,739 | $64,886 | $121,330 |
| Free Cash Flow | -$10,894 | -$21,832 | -$12,313 | -$24,920 |